Hana Biosciences, a biopharmaceutical company focused on advancing cancer care, will join the Russell 3000 Index and the Russell Microcap Index when the Russell Investment Group reconstitutes its family of U.S. Indexes on June 30, 2006. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2733229)